{"tags": [{"id": 143, "search": null, "name": "Cancer Early Diagnosis Guidelines", "code": ""}, {"id": 142, "search": null, "name": "Cancer Screening Guidelines", "code": ""}], "categories": [{"hasContent": true, "id": 55, "search": null, "name": "Clinical Guideline", "code": "CG"}], "versions": [{"publisher": {"id": 71, "search": null, "name": "Ministry of Health", "contact": ""}, "authors": [{"id": 70, "search": null, "name": "Ministry of Health", "contact": ""}], "collaborators": [{"id": 488, "search": null, "name": "FIND Diagnostics", "contact": ""}, {"id": 476, "search": null, "name": "USAID", "contact": ""}, {"id": 9, "search": null, "name": "WHO", "contact": ""}], "fileUrl": "media/National_Cancer_Screening_Guidelines_2024_1.pdf", "id": 486, "search": null, "name": "National Cancer Screening and Early Diagnosis Guidelines", "description": "The purpose of the screening guidelines is to provide a structured framework for early detection of cancer through evidence-based screening and diagnostic practices, tailored to the local epidemiology and healthcare context. This document aims to guide healthcare providers and stakeholders in implementing effective screening programs for priority cancers, improving early diagnosis, and enhancing cancer prevention and control efforts.", "edition": "2nd Edition", "state": "CURRENT", "upload": "./National_Cancer_Screening_Guidelines_2024_1.pdf", "datePublished": "2024-10-01"}], "relatedGuidelines": [], "lastUpdated": "", "id": 534, "search": null, "name": "National Cancer Screening and Early Diagnosis Guidelines", "summary": "The guidelines are divided into four sections:\r\n\u2022\tSection A outlines the epidemiological basis for cancer early detection globally and nationally, covering cancer prevention, early detection, and the guidelines' process, audience, and scope.\r\n\u2022\tSection B focuses on cancer screening, recommending modalities for cervical, breast, colorectal, prostate, retinoblastoma, and oral cancers.\r\n\u2022\tSection C addresses early diagnosis, providing general and cancer-specific guidance for lung, childhood, and oesophageal cancers.\r\n\u2022\tSection D includes appendices on program planning, global strategies, and monitoring and evaluation tools for clinical teams.\r\n\r\n", "description": "The purpose of the screening guidelines is to provide a structured framework for early detection of cancer through evidence-based screening and diagnostic practices, tailored to the local epidemiology and healthcare context. This document aims to guide healthcare providers and stakeholders in implementing effective screening programs for priority cancers, improving early diagnosis, and enhancing cancer prevention and control efforts.\r\n\r\n", "guidelineType": "CLINICAL", "datePublished": "2024-10-01"}